Current Duke Appointments & Affiliations
Biostatistician, Principal
Duke Clinical Research Institute,
Institutes and Centers
Recent Scholarly Works
Evaluating fitness-for-use of electronic health records in ascertaining baseline characteristics and clinical outcomes in clinical trials: insights from the VESALIUS EHR demonstration project.
Journal article Trials · April 25, 2026 INTRODUCTION: A tremendous amount of clinical data is collected and stored in electronic health records (EHRs). Whether this data can be harnessed at scale to facilitate clinical trial conduct remains to be seen. METHODS: The Effect of Evolocumab in Patien ... Full text Link to item CiteA plain language review of the ATTRibute-CM study: efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy.
Journal article Future Cardiol · December 2025 Full text Link to item CiteCharacterization of serum phosphate levels over time with intravenous ferric carboxymaltose versus placebo as treatment for heart failure with reduced ejection fraction and iron deficiency: An exploratory prospective substudy from HEART-FID.
Journal article Eur J Heart Fail · May 2025 AIMS: Ferric carboxymaltose (FCM) is guideline-recommended for iron deficiency (ID) in heart failure with reduced ejection fraction (HFrEF). Despite a well-established safety profile, the magnitude and clinical significance of FCM-induced hypophosphataemia ... Full text Link to item CiteRecent Grants
2/2 IMPRroving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)
ResearchBiostatistician Investigator · Awarded by National Heart, Lung, and Blood Institute · 2023 - 2030PROMISE Trial: SDCC
Clinical TrialSenior Statistician · Awarded by National Institutes of Health · 2009 - 2015View All Grants